VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.10
+0.43 (2.19%)
Jun 18, 2026, 4:08 PM HKT

VISEN Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
632.65203.59347.78626.46
Cash & Short-Term Investments
632.65203.59347.78626.46
Cash Growth
210.75%-41.46%-44.48%-
Accounts Receivable
0.17---
Other Receivables
0.931.774.091.45
Receivables
1.11.774.091.45
Inventory
1.53---
Other Current Assets
306.7817.2222.2583.69
Total Current Assets
942.05222.57374.12711.59
Property, Plant & Equipment
7.711.1613.2617.16
Other Intangible Assets
1.070.050.571.42
Other Long-Term Assets
26.4860.0455.8511.1
Total Assets
977.3293.82443.8741.27
Accounts Payable
5.211.121.0127.98
Accrued Expenses
24.3122.5429.8525.48
Short-Term Debt
170.12---
Current Portion of Leases
2.5822.554.67
Current Income Taxes Payable
1.942.671.852.57
Current Unearned Revenue
--2.92.9
Other Current Liabilities
6.8113.8713.6723.74
Total Current Liabilities
210.9652.1951.8287.34
Long-Term Leases
4.290.361.11.33
Total Liabilities
215.2452.5552.9288.67
Common Stock
0.080.070.070.07
Additional Paid-In Capital
2,4871,5231,5231,523
Retained Earnings
-1,867-1,614-1,431-1,182
Treasury Stock
-0-0.01-0.01-0.01
Comprehensive Income & Other
141.53331.55298.91311.07
Shareholders' Equity
762.05241.28390.88652.61
Total Liabilities & Equity
977.3293.82443.8741.27
Total Debt
176.992.363.656
Net Cash (Debt)
455.66201.23344.13620.46
Net Cash Growth
126.44%-41.53%-44.54%-
Net Cash Per Share
4.402.153.68-
Filing Date Shares Outstanding
109.049.349.34-
Total Common Shares Outstanding
109.049.349.34-
Working Capital
731.09170.39322.3624.25
Book Value Per Share
6.9925.8341.85-
Tangible Book Value
760.99241.22390.31651.19
Tangible Book Value Per Share
6.9825.8341.79-
Machinery
1.761.561.531.59
Leasehold Improvements
1.170.281.763.66